Nachon F, Carletti E, Ronco C, Trovaslet M, Nicolet Y, Jean L, Renard PY (2013)
Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase
Biochemical Journal 453: 393

Nachon F, Carletti E, Wandhammer M, Nicolet Y, Schopfer LM, Masson P, Lockridge O (2011)
X-ray crystallographic snapshots of reaction intermediates in the G117H mutant of human butyrylcholinesterase, a nerve agent target engineered into a catalytic bioscavenger
Biochemical Journal 434: 73

Smirnov IV, Carletti E, Kurkova I, Nachon F, Nicolet Y, Mitkevich VA, Debat H, Avalle B, Belogurov AA, Jr., Kuznetsov N, Reshetnyak A, Masson P, Tonevitsky AG, Ponomarenko NA, Makarov AA, Friboulet A, Tramontano A, Gabibov AG (2011)
Reactibodies generated by kinetic selection couple chemical reactivity with favorable protein dynamics
Proc Natl Acad Sci U S A 108: 15954

Wandhammer M, Carletti E, van der Schans M, Gillon E, Nicolet Y, Masson P, Goeldner M, Noort D, Nachon F (2011)
Structural study of the complex stereoselectivity of human butyrylcholinesterase for the neurotoxic V-agents
Journal of Biological Chemistry 286: 16783

Carletti E, Aurbek N, Gillon E, Loiodice M, Nicolet Y, Fontecilla-Camps JC, Masson P, Thiermann H, Nachon F, Worek F (2009)
Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun.
Biochemical Journal 421: 97

Carletti E, Li H, Li B, Ekstrom F, Nicolet Y, Loiodice M, Gillon E, Froment MT, Lockridge O, Schopfer LM, Masson P, Nachon F (2008)
Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation
Journal of the American Chemical Society 130: 16011

Nachon F, Nicolet Y, Masson P (2005)
[Butyrylcholinesterase: 3D structure, catalytic mechanisms]
Ann Pharm Fr 63: 194

Tormos JR, Wiley KL, Seravalli J, Nachon F, Masson P, Nicolet Y, Quinn DM (2005)
The reactant state for substrate-activated turnover of acetylthiocholine by butyrylcholinesterase is a tetrahedral intermediate
Journal of the American Chemical Society 127: 14538

Nachon F, Nicolet Y, Masson P, Lockridge O, Fontecilla-Camps JC (2004)
X-Ray structures of native and soman-aged human butyrylcholinesterase.
Cholinergic Mechanisms, CRC Press

Nachon F, Nicolet Y, Masson P, Lockridge O, Fontecilla-Camps JC (2004)
Poster (93) How do the crystal structures of human butyrylcholinesterase compare to torpedo californica acetylcholinesterases structures?
In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina: 369

Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, Nachon F (2004)
Poster (49) Crystallographic basis for substrate/product exchange in cholinesterases.
In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina: 347

Loudwig S, Nicolet Y, Masson P, Fontecilla-Camps JC, Bon S, Nachon F, Goeldner M (2003)
Photoreversible inhibition of cholinesterases: catalytic serine-labeled caged butyrylcholinesterase
Chembiochem 4: 762

Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, Nachon F (2003)
Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products
Journal of Biological Chemistry 278: 41141

Nachon F, Nicolet Y, Viguie N, Masson P, Fontecilla-Camps JC, Lockridge O (2002)
Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization
European Journal of Biochemistry 269: 630